What is thymosin α1?
A peptide from the thymus gland that is meant to strengthen the immune system – especially T cells.
How well studied is thymosin α1?
Approved in some countries outside the EU (including China), e.g. for hepatitis B. There are clinical studies; the results are mixed depending on the indication.
What are the side effects and risks of thymosin α1?
Mostly well tolerated; injection site reactions.
Is thymosin α1 approved in Germany?
In short: no – only outside the EU. Not approved in the EU.
Note: We deliberately list no doses here. For approved medications, your doctor sets the dose; for unapproved substances there is no reliable information.